Prosecution Insights
Prosecution Insights
Technology areas: Communications • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
AngioInsight, Inc. operates in the Medical Devices & Mechanical Engineering technology area. The company currently has 2 pending office actions. These actions are distributed across 2 distinct examiners, ensuring that each matter is being evaluated independently. This distribution suggests that the company's applications are subject to multiple perspectives rather than a single point of review.
The prosecution involves 2 distinct art units. This suggests that the company's medical and mechanical innovations are being categorized into different specialized groups at the patent office. Practitioners must be prepared to address the specific nuances and prior art searches characteristic of two separate art units. The variety of units indicates that the portfolio's technical scope is not limited to a single specialized niche.
SABOKTAKIN, MARJAN is the busiest examiner for the portfolio. This examiner is responsible for 1 pending office action. With a busiest examiner pending count of 1, the pending workload is divided equally. This distribution means that the company's success is not tied to a single examiner's discretion but is split across different points of review. Practitioners should focus on the individual requirements of each official.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SABOKTAKIN, MARJAN | 1 | 58.7% | +14.3% |
| WELCH, DAVID T | 1 | 81.3% | +26.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18892184 | Graphical User Interface for Flow Rate Extraction from Angiographic Information | WELCH, DAVID T | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19230677 | DATA-DRIVEN-BASED ANALYSIS OF CORONARY INDEX OF MICROCIRCULATORY RESISTANCE FROM ANGIOGRAPHY DATA | SABOKTAKIN, MARJAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19230677 | DATA-DRIVEN-BASED ANALYSIS OF CORONARY INDEX OF MICROCIRCULATORY RESISTANCE FROM ANGIOGRAPHY DATA | SABOKTAKIN, MARJAN | — |
| 18892184 | Graphical User Interface for Flow Rate Extraction from Angiographic Information | WELCH, DAVID T | — |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| 2613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19230677 | DATA-DRIVEN-BASED ANALYSIS OF CORONARY INDEX OF MICROCIRCULATORY RESISTANCE FROM ANGIOGRAPHY DATA | SABOKTAKIN, MARJAN | 3797 | §101§103 | Final Rejection | — | Pending | Jun 06, 2025 |
| 18892184 | Graphical User Interface for Flow Rate Extraction from Angiographic Information | WELCH, DAVID T | 2613 | §103 | Final Rejection | — | Pending | Sep 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial